3 years to 25 years
Male or Female
Pediatric high-grade gliomas (HGGs), including glioblastoma (GBMs) and anaplastic astrocytoma (AAs), represent approximately 15% of all newly-diagnosed central nervous system (CNS) tumors in children.1 Unfortunately, despite improvement in neurosurgical techniques, radiation therapy (RT) delivery, and trials of various chemotherapy agents, the survival of children with HGG has not significantly changed in the past several decades. No effective curative salvage therapy is available at the time of tumor progression. New treatment strategies for pediatric HGGs are urgently required. In recent years, there have been considerable advances in defining subsets of pediatric HGG by genotyping and expression profiling. BRAF mutation, which constitutively activates the mitogen-activated protein kinase (MAPK) pathway, is one of the most common oncogenic mutations in human cancer. Approximately 10% of pediatric HGG will have BRAF mutations. Given the clinical success of the MAPK pathway inhibitors as both monotherapy and in combination for metastatic melanoma with BRAF mutations, this study is being conducted to evaluate dabrafenib and trametinib in combination after local irradiation for children with BRAF mutant HGG. Our hope is that this combination therapy approach improves event-free and overall survival in this devastating disease.
For further information about this study or to express your interest in this study, please fill out and submit this form.
This setting allows you to view available services and providers associated with your preferred location. You can change this setting at any time.
Cookies are required to view location specific content.
We’ve developed a new tool on our website allowing you to see content most relevant to you and your preferred location. It’s our way of making the information you need, more personalized.
You’ll find this feature labeled “Set My Location” throughout the website. Most often, you’ll see it in the top left corner of every page.
You’ll also find a feature that allows you to set your location temporarily, as seen below.